Status:
COMPLETED
Immediate Skin-To-Skin Contact and Early Breastfeeding During Caesarean Section
Lead Sponsor:
Qingdao Municipal Hospital
Conditions:
Neonatal Hypoglycemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Neonatal hypoglycemia is a prevalent and serious condition among late preterm and term infants, which can lead to severe neurodevelopmental consequences if not managed properly. Immediate ...
Detailed Description
Neonatal hypoglycemia is a common condition among late preterm and term infants. It can lead to severe neurodevelopmental consequences if not managed properly. Immediate skin-to-skin contact (SSC) and...
Eligibility Criteria
Inclusion
- mothers aged 18 years or older with a singleton pregnancy, gestational age between 34+1 and 41+6 weeks.
- undergoing elective cesarean section with epidural, subarachnoid block, or combined spinal-epidural anesthesia, willing to engage in mother-infant SSC during and after the surgery, without experiencing severe reactions to anesthesia like vomiting or shivering that could affect SSC.
- having intention to breastfeed with no major contraindications (e.g., hepatitis B, syphilis, HIV, or other infectious diseases).
- newborns with Apgar scores above 8 at 1 and 5 minutes, a strong sucking reflex, and no critical neonatal conditions requiring transfer.
Exclusion
- serious pregnancy complications such as placenta previa, placenta accreta spectrum, eclampsia, and grade 3 or higher cardiac issues per NYHA standards.
- challenges in initiating mother-infant SSC include emergencies such as neonatal asphyxia or respiratory distress, maternal excessive bleeding during surgery, and maternal infectious dermatoses.
- previous breast surgeries such as biopsies or augmentations, nipple inversions complicating breastfeeding, or taking medications affecting lactation.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2024
Estimated Enrollment :
336 Patients enrolled
Trial Details
Trial ID
NCT06543160
Start Date
July 1 2023
End Date
July 20 2024
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qingdao Municipal Hospital
Qingdao, Shandong, China, 266000